These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 1437699

  • 1. Pharmacokinetics of low-dose methotrexate in adult asthmatics.
    Glynn-Barnhart AM, Erzurum SC, Leff JA, Martin RJ, Cochran JE, Cott GR, Szefler SJ.
    Pharmacotherapy; 1992; 12(5):383-90. PubMed ID: 1437699
    [Abstract] [Full Text] [Related]

  • 2. Bayesian calculation of methotrexate clearance after low dose intramuscular administration in patients with rheumatoid arthritis.
    Monjanel-Mouterde S, Lafforgue P, Blanc A, Catalin J, Aquaviva PC, Durand A.
    J Rheumatol; 1998 Jul; 25(7):1276-81. PubMed ID: 9676756
    [Abstract] [Full Text] [Related]

  • 3. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
    Hroch M, Chladek J, Simkova M, Vaneckova J, Grim J, Martinkova J.
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
    [Abstract] [Full Text] [Related]

  • 4. Early recognition of patients with decreased methotrexate clearance following high-dose methotrexate infusion therapy.
    Ikeda H, Kihira K, Kuwata N, Arai S, Kimura Y, Miyake K, Kitaura T, Fujimura K, Kuramoto A, Fukuchi H.
    Hiroshima J Med Sci; 1996 Jun; 45(2):57-62. PubMed ID: 8810132
    [Abstract] [Full Text] [Related]

  • 5. Total and free methotrexate pharmacokinetics in elderly patients with rheumatoid arthritis. A comparison with young patients.
    Bressolle F, Bologna C, Kinowski JM, Arcos B, Sany J, Combe B.
    J Rheumatol; 1997 Oct; 24(10):1903-9. PubMed ID: 9330930
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics and renal function in patients with rheumatoid arthritis receiving a standard dose of oral weekly methotrexate: association with significant decreases in creatinine clearance and renal clearance of the drug after 6 months of therapy.
    Kremer JM, Petrillo GF, Hamilton RA.
    J Rheumatol; 1995 Jan; 22(1):38-40. PubMed ID: 7699678
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A specific HPLC assay to determine the pharmacokinetics of methotrexate in patients.
    Chen ML, McGuire WP, Lad TE, Chiou WL.
    Int J Clin Pharmacol Ther Toxicol; 1984 Jan; 22(1):1-6. PubMed ID: 6698654
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients. Phase I Study Group of the Association for Medical Oncology of the German Cancer Society.
    Hartung G, Stehle G, Sinn H, Wunder A, Schrenk HH, Heeger S, Kränzle M, Edler L, Frei E, Fiebig HH, Heene DL, Maier-Borst W, Queisser W.
    Clin Cancer Res; 1999 Apr; 5(4):753-9. PubMed ID: 10213209
    [Abstract] [Full Text] [Related]

  • 13. Population pharmacokinetics of methotrexate in the guinea pig.
    Schlatter J, Di Blasi-Bouvet S, Raynaud F, Cisternino S.
    Cell Mol Biol (Noisy-le-grand); 1999 May; 45(3):363-8. PubMed ID: 10386793
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Studies of methotrexate pharmacokinetics in children with neoplasms of the hematopoietic system after administration of different doses of the drug].
    Wysocki M, Krzyzanowski M, Ozyński T, Pilecki O, Balcar-Boroń A, Szadujkis-Szadurski L.
    Acta Haematol Pol; 1992 May; 23(3):179-83. PubMed ID: 1492542
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
    Zhou H, Mayer PR, Wajdula J, Fatenejad S.
    J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.